These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15305148)
1. Acute hydrocephalus upregulates monoamine oxidase mRNA in neonatal rat brain. Kuo MF; Wu KD; Wu RM; Tu YK; Wang HS Neuroreport; 2004 Aug; 15(12):1975-8. PubMed ID: 15305148 [TBL] [Abstract][Full Text] [Related]
2. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. Kato T; Dong B; Ishii K; Kinemuchi H J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508 [TBL] [Abstract][Full Text] [Related]
3. Postnatal development of dopamine deamination in the striatum of the rat. Davis AJ; Holzbauer M; Sharman DF Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563 [TBL] [Abstract][Full Text] [Related]
4. Distinct effects of ketamine and acetyl L-carnitine on the dopamine system in zebrafish. Robinson BL; Dumas M; Cuevas E; Gu Q; Paule MG; Ali SF; Kanungo J Neurotoxicol Teratol; 2016; 54():52-60. PubMed ID: 26898327 [TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. Lamensdorf I; Youdim MB; Finberg JP J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853 [TBL] [Abstract][Full Text] [Related]
7. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis affects the metabolism of catecholamine neurotransmitters in rats. Jiang H; Li F; Liu S; Sun H; Cui Y; Wu Y Neuroscience; 2014 May; 268():112-7. PubMed ID: 24657461 [TBL] [Abstract][Full Text] [Related]
11. Reversibility of the interaction of CGP 11305 A with MAO A in vivo. Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309 [TBL] [Abstract][Full Text] [Related]
12. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Thiblin I; Finn A; Ross SB; Stenfors C Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522 [TBL] [Abstract][Full Text] [Related]
13. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine. Berry MD; Scarr E; Zhu MY; Paterson IA; Juorio AV Br J Pharmacol; 1994 Dec; 113(4):1159-66. PubMed ID: 7889269 [TBL] [Abstract][Full Text] [Related]
14. Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system. Pan X; Guo X; Xiong F; Cheng G; Lu Q; Yan H Toxicol Lett; 2015 Jul; 236(1):60-8. PubMed ID: 25943760 [TBL] [Abstract][Full Text] [Related]
15. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain. Waldmeier PC; Maître L Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597 [No Abstract] [Full Text] [Related]
16. Proceedings: Lack of significance of MAO-B for in vivo deamination of dopamine. Waldmeier PC; Maître L Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R2. PubMed ID: 1143400 [No Abstract] [Full Text] [Related]
17. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Gagnaire F; Chalansonnet M; Carabin N; Micillino JC Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643 [TBL] [Abstract][Full Text] [Related]
18. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar. Huang L; Deng M; Zhang S; Fang Y; Li L Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244 [TBL] [Abstract][Full Text] [Related]
19. Dopamine metabolism in the guinea pig striatum: role of monoamine oxidase A and B. Juorio AV; Paterson IA; Zhu MY Eur J Pharmacol; 1994 Mar; 254(3):213-20. PubMed ID: 8013556 [TBL] [Abstract][Full Text] [Related]
20. Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment. Fornai F; Giorgi FS; Bassi L; Ferrucci M; Alessandrì MG; Corsini GU Brain Res; 2000 Apr; 861(1):126-34. PubMed ID: 10751572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]